Jonathan H Watanabe

15PUBLICATIONS
3CO-AUTHORS
PharmacogenomicsGene and molecular therapyPharmacology and pharmaceutical sciences not elsewhere classifiedOcean law and governanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 08, 2025
Association of Baseline Comorbidities With First-Year Adherence to GLP-1 Receptor Agonists in Patients With Diabetes or Obesity: A Retrospective Cohort Study.

Ziyang Mai, John Kornak, Suzanne M Dufault

|Nov 04, 2025
Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study.

Jonathan H Watanabe, Michael W Strand, Weining Shen

|Jul 22, 2025
Off-label policy through the lens of trazodone usage and spending in the United States.

Srikanth Kadiyala, Matthew Chenoweth, Jonathan H Watanabe

|Jun 04, 2025
Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape.

|Jun 26, 2024
Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States.

Michael W Strand, Jonathan H Watanabe

|May 16, 2022
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large Statewide Health System During the Pandemic in 2020.

Jonathan H Watanabe, Jimmy Kwon, Bin Nan

Pageof 3

Frequent Collaborators

1 joint publications

Judy E Davidson

1 joint publications

Joseph C Larson

1 joint publications

Cynthia A Thomson